chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.08
Sex: F
Vaccine: MMR, VARCEL, DTAP, HIBV, MMR, VARCEL
Symptoms: Pyrexia, Rash erythematous, Rash maculo-papular
Clinical narrative: On 07/10/2000 the patient developed a fever and an erythematous, maculopapular rash on her trunk. It was noted that the patient's mother was in her first trimester of pregnancy and that her immune status was unknown. Additionally, it was noted that measles, rubella and varicella titers were done, however, no results were reported. Follow up information from a physician reported that the "patient is doing well". No further information is available.
Age: 3.5
Sex: F
Vaccine: MMR
Symptoms: Convulsion, Pruritus, Pyrexia, Rash
Clinical narrative: Rash, fever, pruritus - Information has been received from a consumer concerning her 4 year old daughter with a past medical history of possible rolandic seizures and no known allergies who in approximately April 1999 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medications.  Approximately 10 days post-vaccination the patient had a fever and broke out in an itch/rash all over her body.  The patient sought unspecified medical attention.  The patient's sister (WAES #00071056)  had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Follow up information from the physician indicated that the patient had no adverse reactions related to the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  No further information is expected.
Age: 1.25
Sex: M
Vaccine: DTP, HIBV, IPV, MMR
Symptoms: Infection, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old African-American male patient with no known allergies or medical history and no known illnesses who on 19-May2000 was vaccinated subcutaneously with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second genration) (lot 633752/1709J).  Concurrent vaccinations that same day included a fourth dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (lot # 7390-AA) given intramuscularly, a fourth dose of haemophilus b conjugate vaccine ( lot #468-488) given intramuscularly, and a third dose of poliovirus vaccine (IPOL) (lot # R0618) given subcutaneously.  On 26 May 2000 the patient developed a fever of 104F.  It was stated that no obvious rash was noted.  The patient sought unspecified medical attention.  It was reported that an additional patient (WAES # 00070995) had a similar experience following exposure to measles virus vacciine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second genration).
Age: 1.25
Sex: F
Vaccine: DTP, HIBV, IPV, MMR
Symptoms: Infection, Lactose intolerance, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old caucasian female patient with lactose intolerences who on 10 jun 2000 was vaccinated subcutaneously with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # G32456/0173K).  Concomitant vaccinations that same day included a fourth dose via intramuscular administration of diphtheria toxioid (+) pertussia vaccine (+) tetanus toxoid (Lot # U0276RA), a fourth dose via intramuscular administration of haemophilus B conjugate vaccine ( Lot # 622363A), and a third dose via subcutaneous injection of poliovirus vaccine (IPOL) (Lot #r091).  On 20 Jun 2000, the patient experienced a measles like rash.  The patient sought unspecified medical attention.  It was reported that an additonal patient (waes# 00070993) had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella viurs vaccine live (second generation).  Follow up information from the registered nurse indicated that on 20 Jun 2000 the patient developed a rash which started on her face and then spread to her her trunk.  The patient was seen by the physician and the rash was thought to be consistent with a measles rash.  Subsequently the patient has recovered.  No further information is expected.
Age: 4.0
Sex: M
Vaccine: DTP, IPV, MMR
Symptoms: Infection, Rash, Rash morbilliform
Clinical narrative: Morbilliform Rash;  Information has been received from a registered nurse concerning a 4 year old caucasian male patient with no known allergies and no past medical history who on 19 Jun 2000 was vaccinated SC in the right arm with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # 634417/0260K).  Concomitan vaccinations on 19 June 2000 included a fifth dose IM in the left deltoid of diphtheria toxoid (+) pertussia vaccine (+) tetanus toxoid and a fourth dose SC in the left arm of poliovirus vaccine (IPOL).  On 23 Jun 2000 the patient's mother notified the physician's office that the patient had developed a measles-like rash.  follow up information from a registered nurse reported that the patient subsequently recovered.
Sex: F
Vaccine: MMR
Symptoms: Infection, Pruritus, Pyrexia, Rash
Clinical narrative: Rash, fever, pruritus  - Information has been received from a consumer concerning her daughter who in approximately April 1999 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  approximately 10 days post-vaccination the patient had a fever and broke out in a itch/rash all over her body.  The patient sought unspecified medical attention.  The patient's sistem (WAES #00070872) had a similar experienced following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Infection, Otitis media, Pruritus, Pyrexia, Rash
Clinical narrative: Fever, rash, pruritus - Information has been received from a registered nurse concerning a 16 month old East Indian male patient with hypotonia since birth and poor suck and swallow reflex who on 03 Jul 2000 was vaccinated in the left buttock with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation ) (lot #633095 /0254K).  It was noted that the patient was diagnosed with left otitis media at the time of vaccination and was placed on therapy with amoxicillin.  On 12 July 2000 the patient experienced a high fever of 102-103 Fahrenheit and a generalized itchy rash.  The patient was advised to give her son a fever reducer and a lukewarm bath.  If the fever peraisted she was to bring the baby into the office.  On 15 Jul 2000 the patient recovered.  Two additional patient (Wases # 000713119) had a similar experience.  The reporter expressed a concern with the lot number.  No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Infection, Pyrexia, Rash
Clinical narrative: Fever, Rash -  Information has been received from a registered nurse concerning a male patient who was vaccinated with one dose measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #633095/0254K).  subsequently the patient experienced a high fever of 104 fahrenheit and a generalized itchy rach.  unspecified medical attention was sought.  Two additional patients (Waes is 00071009 & 00071118 had a similar experience.  The reporter expressed a concern with the lot number.   Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Infection, Pyrexia, Rash
Clinical narrative: Rash, Fever - Information has been received a registered nurse from concerning a 15 month old female patient who on 6 Jul 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #633095/0254K).  On 14 Jul 2000 the patient experienced a generalized rash and a fever of 39.8 celsius.  unspecified medical attention was sought.  On 16 Jul 2000 the patient recovered.  Addition information has been requested.
Age: 40.0
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Lack of Response- Information has been received from a health care professional concerning an approximately 40 year old pregnant female who is approximately 1990 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently the patient was negative on titer.  Follow up was received which indicated the reporter did not fell as if this case was and adverse event.  additional information has been requested.
Age: 1.08
Sex: F
Vaccine: HIBV, MMR
Symptoms: Asthenia, Emotional distress, Fatigue, Infection, Lethargy
Clinical narrative: Asthenia / fatigue; Mental status change, photophobia, roseola -  Information has been received from a physician concerning a 1 year old female who on 26 June 2000 was vaccinated with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Concomitant therapy included the first dose of Haemophilum S conjugate vaccine (Hib Titer).  On 05 Jul 2000 the patient experienced a fever and lethargy.  The patient then developed a macular papular rash which began on her face and descended to the rest of the body.  On 08- July 2000 the patient experienced photophobia and had a questionable mental change.  The patient sought medical treatment.  Lab work from 17 Jul 2000 revealed a positive IgG and Igm was negative for antibodies to the measles virus.  A white count was 6000 with a differential that included 69% lymphocytes.  The reporting physician thought it was roseola.  On 12 Jul 2000 the patient recovered from all of her symptoms.  Additional information has been requested.
Age: 1.08
Sex: F
Vaccine: HIBV, MMR
Symptoms: Photophobia, Pyrexia, Rash maculo-papular
Clinical narrative: Asthenia / fatigue; Mental status change, photophobia, roseola -  Information has been received from a physician concerning a 1 year old female who on 26 June 2000 was vaccinated with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Concomitant therapy included the first dose of Haemophilum S conjugate vaccine (Hib Titer).  On 05 Jul 2000 the patient experienced a fever and lethargy.  The patient then developed a macular papular rash which began on her face and descended to the rest of the body.  On 08- July 2000 the patient experienced photophobia and had a questionable mental change.  The patient sought medical treatment.  Lab work from 17 Jul 2000 revealed a positive IgG and Igm was negative for antibodies to the measles virus.  A white count was 6000 with a differential that included 69% lymphocytes.  The reporting physician thought it was roseola.  On 12 Jul 2000 the patient recovered from all of her symptoms.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Infection, Rash
Clinical narrative: Rash - Information has been received from a company representative concerning a 12 month old male patient who on 22 May 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Conmitant vaccination that same day included one dose of varicella virus vaccine live (KSD).  On 26 May 2000, the physician was informed that the patient developed red maculopapular eruptions scattered over his body.  Unspecified medical attention was sought.  Follow up information from the health care facility indicated that there were no other adverse reaction
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Infection, Pyrexia, Rash morbilliform
Clinical narrative: Measles - Information has been received from a pharmacist concerning her 15 month old female relative with no past medical history or allergies who on 11 Jul 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (Lot # 630633/0102K).  There was no concomitant medication.  Right days late, the patient developed a mild fever.  Ten days post-vaccination, the patient developed a rash and then the next day she was covered in rash from head to toe.  The patient sought medical attention from a physician who diagnosed it as a case of measles.  The reporter stated there was no exposure to natural measles.  Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Erythema, Infection, Injection site erythema, Injection site swelling, Joint range of motion decreased
Clinical narrative: Range Of Motion Decreased; Injection site erythema; injection site swelling; pain - Information has been received from a registered nurse concerning an 11 year old white female patient who was inadvertently vaccinated on 24 July 2000 with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) IM in the left deltoid rather that the recommended SC route (lot number: 634035/37103).  concomitant vaccinations that  same day included a first dose of hepatitis b vaccine (engerix-b) IM in the right deltoid (lot number: em 33232a4).  Follow up information from a relative  of the patient indicated that one hour and fifteen minutes post-vaccination, the patient developed increased pain and decreased range of motion with localized redness and swelling for approximately one week before symptoms were completely resolved.  On 01 Aug 2000 the patient recovered.  The patient sought unspecified medical attention.  Attitional information has been requested.
Age: 11.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Pain
Clinical narrative: Range Of Motion Decreased; Injection site erythema; injection site swelling; pain - Information has been received from a registered nurse concerning an 11 year old white female patient who was inadvertently vaccinated on 24 July 2000 with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) IM in the left deltoid rather that the recommended SC route (lot number: 634035/37103).  concomitant vaccinations that  same day included a first dose of hepatitis b vaccine (engerix-b) IM in the right deltoid (lot number: em 33232a4).  Follow up information from a relative  of the patient indicated that one hour and fifteen minutes post-vaccination, the patient developed increased pain and decreased range of motion with localized redness and swelling for approximately one week before symptoms were completely resolved.  On 01 Aug 2000 the patient recovered.  The patient sought unspecified medical attention.  Attitional information has been requested.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Infection, Rash
Clinical narrative: Rash - Information has been received from a registered nurse concerning a 32 year old female patient who on 11 Jul 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient developed a small, diffuse rash on her body including her trunk, face and extremities.  Additional information has been requested
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, VARCEL, HIBV, MMR, VARCEL
Symptoms: Infection, Pruritus, Rash papular, Skin disorder
Clinical narrative: Information has been received from a company representative concerning a 12 month old male pt who on 6/7/00 was vaccinated with MMRII, varicella and a 4th dose of haemophilus b conjugate vaccine. On 6/26/00, the pt developed a rash on his arms and legs and itchy umbilicated papules on his upper body and extremities. The physician indicated that the rash was molluscum contagious. The pt was not hospitalized. It was reported that the pt subsequently recovered. Follow-up information from the health care facility received on 11/6/00, indicated that no other adverse reactions occurred. No further information is expected.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, VARCEL, HIBV, MMR, VARCEL
Symptoms: Asthma, Infection, Pruritus, Rash
Clinical narrative: Information has been received from a company representative concerning a 12 month old male pt who on 6/7/00 was vaccinated with MMRII, varicella and a 4th dose of haemophilus b conjugate vaccine. On 6/26/00, the pt developed a rash on his arms and legs and itchy umbilicated papules on his upper body and extremities. The physician indicated that the rash was molluscum contagious. The pt was not hospitalized. It was reported that the pt subsequently recovered. Follow-up information from the health care facility received on 11/6/00, indicated that no other adverse reactions occurred. No further information is expected.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, VARCEL, HIBV, MMR, VARCEL
Symptoms: Infection, Pruritus, Rash papular, Skin disorder
Clinical narrative: Molluscum, Contagiosum, Pruritus - Information has been received from a physician concerning a 12 month old black male with a history of asthma and tibial torsion who on 07-Jun 2000 was vaccinated with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) 0.5 ml (lot# 632400/1082j) in the left arm. Concomitant therapy included the first dose of varicelia virus vaccine live (MSD) o.5 ml (lot #632364/14565) in the right arm.  Other concomitant therapy included the fourth dose of hib conjugate vaccine o.5 ml in the right thigh.  On 26 Jun 2000 the patient developed a rash consisting of flesh - colored umbilicated papules on face, abdomen, arms and legs.  The patient was diagnosed as having molluscum contagiosum.  The patient received treatment with hydroxyzine hydrochloride liquid (Atarax) for itching as neeed.  Otherwise, supportive care was given.  The patient recovered on 30 Jun 2000 by the grandmother's report.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, VARCEL, HIBV, MMR, VARCEL
Symptoms: Asthma, Infection, Pruritus, Rash
Clinical narrative: Molluscum, Contagiosum, Pruritus - Information has been received from a physician concerning a 12 month old black male with a history of asthma and tibial torsion who on 07-Jun 2000 was vaccinated with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) 0.5 ml (lot# 632400/1082j) in the left arm. Concomitant therapy included the first dose of varicelia virus vaccine live (MSD) o.5 ml (lot #632364/14565) in the right arm.  Other concomitant therapy included the fourth dose of hib conjugate vaccine o.5 ml in the right thigh.  On 26 Jun 2000 the patient developed a rash consisting of flesh - colored umbilicated papules on face, abdomen, arms and legs.  The patient was diagnosed as having molluscum contagiosum.  The patient received treatment with hydroxyzine hydrochloride liquid (Atarax) for itching as neeed.  Otherwise, supportive care was given.  The patient recovered on 30 Jun 2000 by the grandmother's report.  Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Feeling hot, Swelling, Urticaria
Clinical narrative: Information has been received from a licensed visiting nurse concerning an unidentified pt who was vaccinated with a 1st dose of inadvertently vaccinated with a 2nd dose of MMRII on 9/19/99 and 07/31/00, respectively. Subsequently, after the 2nd dose, on 7/31/00, the pt experienced "swelling, 1/2" wheal and an area that is red and hot." The pt sought unspecified medical attention. Additional information has bee requested.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR
Symptoms: Erythema, Erythema multiforme, Hypersensitivity, Skin ulcer, Urticaria
Clinical narrative: Information has been received from a licensed practical nurse concerning a 15 month old female pt with a history of erythema multiforme following exposure to varicella virus vaccine live (MSD) (WAES 00072512) who was vaccinated with a 1st dose of MMRII SC in the left leg. That same day the pt also had a 4th dose of Haemophilus B conjugate vaccine IM in the left leg. On 7/26/00, the pt developed erythema multiforme. Unspecified medical attention was sought and the pt's experience was thought to be an allergy and treated at the time of the occurrence. Follow-up information from a physician indicated that "10 days, post vax, the pt developed red target lesions and urticarial rash (had a similar reaction to the varicella virus vaccine before". On 7/30/00, the pt recovered.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a licensed practical nurse concerning a 15 month old female pt with a history of erythema multiforme following exposure to varicella virus vaccine live (MSD) (WAES 00072512) who was vaccinated with a 1st dose of MMRII SC in the left leg. That same day the pt also had a 4th dose of Haemophilus B conjugate vaccine IM in the left leg. On 7/26/00, the pt developed erythema multiforme. Unspecified medical attention was sought and the pt's experience was thought to be an allergy and treated at the time of the occurrence. Follow-up information from a physician indicated that "10 days, post vax, the pt developed red target lesions and urticarial rash (had a similar reaction to the varicella virus vaccine before". On 7/30/00, the pt recovered.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Rash, Urticaria
Clinical narrative: Information has been received from a company representative concerning a 4 year old female who on 7/27/00 was vaccinated with a dose of MMRII. Subsequently, the pt experienced a rash and welts. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been rec'd from a company representative who rec'd the info from a Nsg concerning a pt who on an unspecified date was vaccinated with 1 dose of MMR vaccine. 2 to 3 wks post vaccine, the pt developed a disseminated measles type rash. The reporter was unable to provide the lot # at the time of the report. The pt sought unspecified medical attention. Also reported was a male pt  (WAES# 00110044) who was vaccinated and experienced similar events. No further info is available.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema
Clinical narrative: Immediately post vaccination, the pt developed erythema at the injection site. the erythema faded within 5 minutes of onset. The pt was observed for 15 minutes and was reported as being ok. It was noted that 5 weeks prior vaccination the pt had a similar reaction to varicella vaccine.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Headache, Infection, Parotid gland enlargement, Pharyngolaryngeal pain
Clinical narrative: On 04/30/00 pt developed a sore throat, runny nose, headache, and fever. On 05/30/00 the pt presented at clinic and was found to have enlarged bilateral parotid glands. On 05/04/00 a mumps titer was drawn and came back equivocal. The health department stated that this a a lab (-) case of mumps. ON 05/12/00, the pt recovered, however, on 07/21/00 a convalescent IgG was drawn which remained at greater than four-fold increase. No further information is expected.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Rhinorrhoea
Clinical narrative: On 04/30/00 pt developed a sore throat, runny nose, headache, and fever. On 05/30/00 the pt presented at clinic and was found to have enlarged bilateral parotid glands. On 05/04/00 a mumps titer was drawn and came back equivocal. The health department stated that this a a lab (-) case of mumps. ON 05/12/00, the pt recovered, however, on 07/21/00 a convalescent IgG was drawn which remained at greater than four-fold increase. No further information is expected.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Laboratory test abnormal, Testicular disorder
Clinical narrative: On 7/7/00 the pt presented to the ER with orchiditis. His left testicle was swollen. A measles/rubella titer was obtained to rule out mumps. The IgG test was reactive for rubella and measles, however mumps was negative. An IgM for mumps was ordered and revealed borderline acute illness. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Dizziness, Drug ineffective, Fatigue, Infection
Clinical narrative: Cutaneous Nodule, Dizziness, Asthenia/Fatigue, Secondary transmission  - Information has been received from a female consumer who was exposed to her one year old female niece who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (date not reported).  Subsequently, the reporter sexperienced bumps on face and a few scattered throughout the rest of her body.  She also experienced dizziness and lethargy.  The experience of the one year old female is reported in waes# 00111523.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Injection site mass, Lethargy, Subcutaneous nodule
Clinical narrative: Cutaneous Nodule, Dizziness, Asthenia/Fatigue, Secondary transmission  - Information has been received from a female consumer who was exposed to her one year old female niece who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (date not reported).  Subsequently, the reporter sexperienced bumps on face and a few scattered throughout the rest of her body.  She also experienced dizziness and lethargy.  The experience of the one year old female is reported in waes# 00111523.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Infection, Pyrexia
Clinical narrative: Fever - Information has been received from a physician concerning a male patient who on 03 Jan 1994, at 2 months old was vaccinated with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently the patient experienced a fever.  Unspecified medical attention was sought.  The patient received the next two doses of measles (+) mumps (+) rubella virus vaccine live (second generation)  according to the schedule.  The physician inquired as to whether or not there would be a problem with administering a fouth dose of mealses (+) mumps (+) rubella virus vaccine live (second generation).  Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Hypokinesia, Infection
Clinical narrative: Lack OF Response - Information has been received from a registered nurse concerning a 26 year old while female reqistered nurse who on an unspecified date was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient was tested only for antibodies to rubelin which were  negative.  The patient sought unspecified medical attention.  Follow up information received on 19 sep 2000 from a physician's assistant indicated that on 15 sept 2000 the patient received a third dose of rubella virus vaccine live (second generation no further information is available.
Sex: F
Vaccine: MMR
Symptoms: Infection, Pyrexia
Clinical narrative: Fever- Information has been received from a consumer conserning her daughter who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Sebsequently, the patient developed a high fever.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Infection, Injection site erythema, Urticaria
Clinical narrative: Injection site erythema narrower than 1 inch; injection site wheal - information has been received from a licensed practical nurse concerning a 12 month old caucasian male patient who on 03- Aug 2000 at 1:30 pm. was vaccinated subcutaneously in the right thigh with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (635125/0400k).  Concomitant vaccinations that same day included a first dose of varicella virus vaccine live (msd) (lot #632613/1857J) administered subcutaneously via the left thigh.  The patient developed a large wheal at the injection site that when treatec with ice resolved within 30 minutes.  The reporter stated concern regarding the lot of the vaccine.  It was reported that 3 other patients (waes 00382071 through 00082073 ) had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Follow up information from the licensed practical nurse indicated that on 03 Aug 2000 the patient developed redness at the injection site 2 cm in diameter.  It was reported that subequently the patient recovered.  No further information is expected.
Sex: U
Vaccine: MMR
Symptoms: Infection, Injection site erythema, Injection site swelling
Clinical narrative: Injection site swelling, injection site erythema - Information has been received from a pharmacist concerning an unidentified patient who was vaccinated subcutaneously in the forearm with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.  Subsequently the patient developed a huge red swelling at the site of injection.  The patient sought unspecified medical attention.  Attitional information has been requested.
Age: 9.0
Sex: F
Vaccine: MMR
Symptoms: Infection, Injection site erythema, Injection site swelling
Clinical narrative: Injection site erythema, Injection site swelling - Information has been received from a physican concerning a 9 year old caucasian female patient with a history of cellulities after vaccination with a fifth dose of diphtheria - tetantus toxoids - acellular pertussia vaccine, who on 18 Aug 2000 was vaccinated with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation (lot #635288/0583K).  Within 30 minutes after vaccination, the patient developed erythema, and slight swelling surrounding the injection site.  foxofonadine (Allegra) was administered to the patient at the doctor's office.  It was reported that the patient's mom was upset, and they wer told to apply ice and diphenhydramine HCL (Benadryl).  The Patient has antibiotic allergies to penicillin and arithromycin (zithromax).  The patient has recovered.
Sex: F
Vaccine: MMR
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: On 08/17/2000 the patient developed a fever of greater than 101F and was very achy. The following day the patient felt very fatigued throughout the weekend. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MMR
Symptoms: Infection, Injection site reaction, Urticaria
Clinical narrative: Injection Site Wheal - Information has been received from a health care professional concerning an 11 year old male patient who in approximately August 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live ( second generation ) (635125/0400K).  Subsequently the patient developed a large wheal at the injection site that when treated with ice resolved within 30 minutes.  The reporter stated concern regarding the lot of the vaccine.  It was reported that 3 other patients (WAES # 00081640, 000829072 and 00082073)  had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  No further information is expected.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Infection, Injection site reaction, Urticaria
Clinical narrative: Injection site wheal - Information has been received from a health care professional concerning a 10 year old male patient who in approximately August 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation ) (635125/0400K).  Subsequently the patient developed a large wheal at the injection site that when treated with ice resolved within 30 minutes.  The reporter stated concern regarding the lot of the vaccine.  It was reported that 3 other patient  (WAES #00081640, 00082071, and 00082073) had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) . Additional information has been requested.
Age: 1.08
Sex: M
Vaccine: MMR
Symptoms: Infection, Injection site reaction, Urticaria
Clinical narrative: Injection site Wheal - Information has been received from a health cre professional concerning a 1 year  old male patient who is approximately August 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (635466/0782k).  Subsequently the patient developed a large wheal at the the injection site that when treated with ice resolved within 30 minutes.  the reporter stated concern regarding the lot of the vaccine.  It was reported that 3 other patients (Waes #0008164, 00082071 and 000282072) had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  No further information is expected.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Nonspecific reaction
Clinical narrative: It was noted at the time of the vaccination there were no illnesses. On approximately 03/07/2000 the patient sought unspecified medical attention and was found to not have any detectable IpG antibodies to rubella. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Agitation, Anaphylactic reaction, Pyrexia
Clinical narrative: Post vax the patient experienced an anaphylactic reaction to the vaccine. Medical attention was sought and the reporting physician felt the reaction was related to the MMR vaccine. On 03/29/1996 the patient experienced a high fever of 104.8F. She was less active, was crying and whining although she had been taking fluids and wetting her diaper. There was no vomiting or diarrhea. The physical examination was normal. The patient was treated with ibuprofen. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Rash - Information has been received from a pharmacist concerning a patient who was vaccinated with one with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Two to three weeks post vaccination the patient developed a rash (not described).  Unspecified medical attention was sought. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Otitis media, Pyrexia, Rash
Clinical narrative: Measles, Fever - Information has been received from a lisensed practical nurse concerning a 12 month old caucasian male patient with a history of otitis media, and pre - existing conditions of a tongue disorder and asymmetry of his ears who in approxiamately 1996 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  On 31 may 1996 the patient developed a measles type rash.  Unspecified medical attention was sought.  Follow up information from a physician indicated that on 31 May 1996 the patient developed a fever and severe rash.  The patient was seen by a physician an 05 Jun 1995 with a rash consistent with mealse.  Three weeks post onset, the patient recovered.
Age: 30.0
Sex: M
Vaccine: MMR
Symptoms: Discomfort, Infection, Malaise, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning an approx. 30 year old male pt from another country, who was vaccinated with a dose of MMRII. Subsequently, the pt developed measles. The pt sought unspecified medical attention. Follow-up information from the physician indicated that approx. 10 days, post vax, the pt developed a speckled rash over his trunk with a low-grade fever and some discomfort, questionable malaise. The physician indicated that it was a mild case of measles and he recommended the causal interventions; rest, fluids, acetaminophen, no aspirin and to return promptly to the physician's office if any symptoms worsen. It was reported that the pt was not known to be previously vaccinated against measles. Additional information was requested.
Age: 1.3
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Infection, Injection site reaction, Urticaria
Clinical narrative: Injection site wheal - Information has been received from a physician concerning a 16 month old male patient who was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot 632532/1270J in the arm.  Concomitant vaccinations administered that same day included one dose of varicella virus vaccine live (msd) in the arm.  It was noted that the 2 vaccinations were administered in opposite arms.  Within 5 minutes of vaccination, the patient developed a local reaction at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation injection site described as a twentyfive cent urticarial lesion.  There were no other symptoms.  The patient was treated with diphenhydramine HCL Benadryl.    The patient's symptoms resolved in less than 1 hours.  There was no reaction to varicella virus vaccine live (MSD).  The patient had a serum multiallergen radioallergoeorbent test and was found to be negative for gelatin and egg.  It was noted that 2 months later the patient was vaccinated with Hib (lederle vaccine) and had a similar reaction.
Sex: F
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Lack Of response-  information has been received from a registered nurse concerning a female foreign student who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.  Sebsequently, it was reported that titer levels were not detactable for rubella.  Unspecified medical attention was sought.  Additional information had been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Asthma, Cellulitis, Erythema, Infection, Injection site induration
Clinical narrative: Application Site reaction: cellulitis; induration - Information has been received from a health professional concerning a 37 year old caucasian female patient with a history of asthma who on 30 Aug 2000 was vaccinated SC on the right with a third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot #629535/1507J.  On 31 Aug 2000 the patient developed a red spot for one week and was treated with ibuprofen.  On 11 sep 2000 the patient was seen by a  physician for increased redness and swelling.  It was noted that there was a 55mm induration.  There were no nodes in arm pit.  The diagnosis was local reaction with questionable early celluitis.  The patient was given a tetanus booster, cephalexin keflex mg qid x 7 days and hydrocortisone valerate westocort cream.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Injection site reaction, Swelling
Clinical narrative: Application Site reaction: cellulitis; induration - Information has been received from a health professional concerning a 37 year old caucasian female patient with a history of asthma who on 30 Aug 2000 was vaccinated SC on the right with a third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot #629535/1507J.  On 31 Aug 2000 the patient developed a red spot for one week and was treated with ibuprofen.  On 11 sep 2000 the patient was seen by a  physician for increased redness and swelling.  It was noted that there was a 55mm induration.  There were no nodes in arm pit.  The diagnosis was local reaction with questionable early celluitis.  The patient was given a tetanus booster, cephalexin keflex mg qid x 7 days and hydrocortisone valerate westocort cream.
Age: 1.25
Sex: U
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Five days post vax, pt experienced a fever. Unspecified medical attention was sought. Addtl info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Pt experienced a rash and fever post vax. Medical attention was sought. No further info is available.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Two days post vax pt experienced fever of 104.6. Medical attention was sought. No further info is available.
Sex: F
Vaccine: VARCEL
Symptoms: Myelitis transverse
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with varicella virus vaccine live. Fourteen days, post vax, the pt experienced transverse myelitis. The transverse myelitis was considered to be an "Other Medical Event". Additional information has been requested.
Age: 33.0
Sex: M
Vaccine: VARCEL
Symptoms: Joint swelling, Serum sickness, Urticaria
Clinical narrative: Information has been received from a physician concerning a 33 year old male with an allergy to penicillin who on 2/1/01 was vaccinated with the 1 dose of varicella virus vaccine live (lot 636569/0926K). On 2/7/01, the pt experienced hives and not a varicella-like rash. The rash was non-raised. He was seen in the ER. Upon medical review, the hives were determined to be an "Other Medical Review". The pt was treated with a steroid and Benadryl, but did not have much relief. Additionally, on 2/9/01, the pt experienced swelling in his joints and serum sickness-like symptoms. The pt's hives persisted. The outcome of the pt's other experiences was not reported. No further information is available.
Age: 6.9
Sex: M
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site induration, Injection site reaction, Injection site warmth
Clinical narrative: Information was received from a registered nurse and a physician concerning a 6 year old white male who on 01/08/01 was  vaccinated SC in the right arm with a 1st dose of Varicella virus live. There was no illness at the time of vaccination. There were no concomitant medications reported. On approximately 01/17/01, the father of the patient reported to the physician's office that he noticed that his son had developed a "red, warm area, about the size of a quarter" at the injection site (right arm). On 01/19/01, the patient presented to the physician's office (also indicated by the physician as "no doctor visit") with a 5x5 cm erythema near the injection site, a 3x3 cm induration near the injection site. In follow-up the physician reported the child had developed "early cellulitis of the arm at the site of injection" on 01/19/01. The child was being treated with unspecified oral antibiotics. Upon internal review, signs of cellulitis, was determined to be an other important medical event. Follow-up information has been received that states the patient had cellulitis of the right upper arm that started on approximately 01/17/01 and lasted for one week. The patient was treated with oral antibiotics and the problem resolved. Additional information is not expected.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: The pt experienced allergic reaction, post vax, which was dx'd as cellulitis. Unspecified medical attention was sought and she was placed on therapy with Duricef for 1 week. The pharmacist reported that the pt discovered she was 6 weeks pregnant in the beginning of January. Her estimated date of delivery was 9/6/01. Upon internal review, cellulitis was determined to be an other important medical event. In follow up, the pharmacist reported that her sister delivered a healthy  baby boy at term with no problems noted. The infant wasborn on approximately 09/17/01 and is "doing well" Additional information is not expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Eye disorder, Herpes zoster, Infection
Clinical narrative: Information has been received from a Physician's Assistant concerning a 3 year old female who in 1998 was vaccinated with Varicella Virus live. In May 2000, the patient developed herpes zoster of the eye and was hospitalized. Additional information has been requested
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Diarrhoea, Headache, Myalgia, Nausea
Clinical narrative: On 9/21/00, pt experienced a fever of 102.6, headache, muscle pain, joint pain, nausea without vomiting, and diarrhea. Medical attention was sought. No further info is available.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: On 9/21/00, pt experienced a fever of 102.6, headache, muscle pain, joint pain, nausea without vomiting, and diarrhea. Medical attention was sought. No further info is available.
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Pt was vaccinated with 2 doses of MMRII. Post vax pt experienced a negative antibody test for rubella. No further info is available.
Age: 1.08
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Day of receiving vax, pt developed redness at injection site 1 cm in diameter. Subsequently pt recovered.
Age: 11.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Injection site erythema
Clinical narrative: The day of receiving vax pt experienced redness at the injection site 2 cm in diameter. On an unspecified date the pt recovered. Another pt (WAES00092217) had a similar experience following exposure to MMRII. No further info is available.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema
Clinical narrative: On 8/3/01 the pt experienced redness at the injection site, 1.5 x 2 cm in diameter. On an unspecified date, the pt recovered. Another pt (WAES00092216) had a similar experience following exposure to MMRII. No further info is available.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Dysuria, Pollakiuria
Clinical narrative: Information has been received from a pharmacist concerning a pt who after vaccination experienced painful urination and frequency in urination. The pt also had an IUD in place. Medical attention was sought. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Blister, Infection, Pharyngitis, Pharyngolaryngeal pain, Rash morbilliform
Clinical narrative: Blister; Morbilliform Rash; streptococcal pharyngitis;  Information has been received from a licensed practical nurse concerning an unidentified female patient who on 29 Aug 2000 was vaccinated with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.  On 18 sep 2000 the patient developed blisters on her hands, feet and in her mouth and was seen by the physician.  The patient also had a sore throat which was positive for strep and she was placed on amoxicllin at that time.  She returned to the physician on 26 Sep 2000 with a measles like rash that the physicain felt might be a reaction to the amoxicillin.  Additonal information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a company representative concerning 3-5 children (males and females) who in 9/00, were vaccinated with MMRII (lot 636658/1141K). Seven days, post vax, the pts experienced rash and/or fever to 102F. There was a concern because all of the pts received vaccine from the same lot. The records of testing prior to release of this lot have been checked by Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. In follow-up, the physician reported she "did not have those records any longer and the reactions are as detailed as she knew." The physician reported that she was just reporting "an increased frequency of issues with one lot of vaccines, last year and did not have more details." No further information is available.